NewsSource: EClinCloud

New Technologies for Rating Scale Assessment in Psychiatric and Psychological Clinical Research: Rater Training

4 min readEClinCloud Editorial Team
Article image

Source: EClinCloud. Author: eClinCloud.


Click the blue text above to follow us

Article image



On August 24–27, 2021, the "Training Series on Clinical Research Technologies and Capacity Building for Psychiatric and Psychological Disorders" was successfully held. Dr. Qin Long, CEO of EClinCloud, was invited to give a keynote presentation on "New Technologies for Rating Scale Assessment in Psychiatric and Psychological Clinical Research." He provided a comprehensive introduction to three new technologies currently used in rating scale assessment: eCOA, rater training, and blinded data analysis, and shared case examples demonstrating how these new technologies support clinical research.


We will introduce these three new technologies across three articles; this article covers Part 2: rater training.



Article image

Rating scales provide valuable evidence for physicians in diagnosing diseases, and because many psychiatric scales serve as primary endpoints in clinical trials, they need to accurately measure and assess patients' psychological characteristics. Therefore, to make assessment results as accurate as possible, scoring error must be strictly controlled. An important way to control scoring error is to standardize the assessment—that is, to ensure procedural consistency in administering, scoring, and interpreting the assessment so that all patients are evaluated under the same conditions.

Standardized assessments require standardized administration methods, so it is crucial that raters can conduct assessments accurately in accordance with scale requirements. Using validated methods and approaches, we provide comprehensive rater training to reduce human error, standardize scoring, ensure consistency of assessment results, and improve the reliability of endpoint outcomes.


To reduce placebo effects and scoring bias

Both investigators and patients need to receive relevant training

Investigators need to create a good assessment environment

Patients also need to have appropriate expectations about the clinical trial


Investigator side

Throughout the process, care should be taken to balance interactions with patients, manage patient expectations, keep contact minimal, listen more, and communicate directly.

Article image
Patient side

Their expectations and mindset need to be well managed so that they maintain realistic expectations and avoid blind optimism, understanding that it is acceptable even if symptoms remain unchanged or worsen.

Article image


Throughout the trial, conducting rater training to maintain the accuracy and standardization of endpoint assessment is an ongoing process.

Some studies last a relatively long time—two, three, or even more years. To keep subjective scales objective over such an extended period, raters need ongoing training. For certain specific scales, not only is the training validity period short, but training records are also required; for example, for the NIHSS scale, each training is valid for only one year, and retraining is required after one year.

In addition, the trial process may also include periodic refresher training as well as remedial training conducted based on issues identified during data quality monitoring in the study.


Article image
Rater Training Process
Step 1

Before training, raters need to submit an experience questionnaire so that we can understand their prior background, such as how many years of rating experience they have and which scales they are familiar with. An interview skills assessment is also conducted to evaluate the rater's interviewing ability and approach. More experienced and skilled raters may be exempted from most training, whereas less experienced or novice raters may receive more intensive training.

Step 2

Select suitable raters once qualification requirements are met.

Step 3

Conduct online or in-person training on interviewing and assessment skills through investigator meetings or a learning platform using various interactive learning tools. Training content may also cover topics such as subject selection, adherence to scale rules, synchronization of symptom measurement, and mitigation of placebo effects.


Final step

Confirm qualified raters for each study site.



Through this entire training process

Ensure rater training spans the entire clinical trial

Improve rating consistency

Ensure endpoint quality


Article image


EClinCloud

With the mission of "bringing effective treatments to patients through technological innovation," EClinCloud is a healthcare and life sciences technology company based in China and serving the world. Through EClinCloud's end-to-end, seamlessly integrated unified cloud platform (including solutions such as CTMS, EDC, eTMF, eCOA, eConsent, and RTSM, as well as consulting services such as scale management, linguistic validation, and study design) and clinical trial endpoint assessment technologies across diverse therapeutic areas (including oncology, neurology, cardiology, pulmonology, and dermatology), EClinCloud builds a globally leading, "patient-centric" integrated SaaS cloud platform for clinical evidence support, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the launch of drugs/devices, and benefit countless patients.
Article image


Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.